Instalab
logoInstalab

Aflatoxin B1

Urine Test
Get an early read on recent food exposure to a mold toxin closely tied to liver cancer.
4.9 (2,939 reviews)
Tested by Vibrant America
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Collect your sample
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a AFB1 test?

This test is most useful if any of these apply to you.

Eating Corn, Peanuts, and Spices Often
If staples like maize, groundnuts, rice, or spices are a big part of your diet, this shows whether a mold toxin is coming in with them.
Living With Hepatitis B or C
Chronic hepatitis multiplies aflatoxin-related liver cancer risk, so knowing your recent exposure carries far more weight for you.
Sourcing Food From Warm, Humid Regions
If your food comes from places with hot climates or informal storage, this reveals whether contamination is reaching your body.
Healthy but Watching Hidden Exposures
If you track environmental and dietary toxins, this offers an exploratory window into a carcinogen routine labs never measure.

About Aflatoxin B1

If you eat a lot of corn, peanuts, rice, dried fruit, or spices, especially from places with hot, humid climates or informal food storage, some of what you swallow can carry a mold-made poison called aflatoxin. This urine test shows whether that poison has moved through your body in the last few days.

Long-term aflatoxin exposure is one of the best-documented dietary causes of liver cancer in humans, and the danger climbs steeply if you also carry hepatitis B or C. A urine result gives you a window into recent exposure that no standard blood panel checks for.

What This Test Actually Measures

The test looks for AFB1 (aflatoxin B1), a fungal food poison, and its breakdown products in your urine. In practice, much of what shows up is not the original toxin but AFM1 (aflatoxin M1), one of the main products your liver makes after you swallow AFB1. The liver also makes other breakdown products, such as AFQ1, which can appear at even higher levels in some people. Some samples contain the unchanged toxin, but a metabolite like AFM1 is usually the more sensitive signal for the antibody-based tests most often used.

This is an exploratory exposure marker, not a diagnosis. It tells you the toxin recently entered your body, not that you have any disease. Only a small share of the aflatoxin you eat, with human studies reporting roughly 1 to 7%, leaves as urinary AFM1, so the test detects exposure well but is a rough gauge of the exact amount you took in.

A Recent-Exposure Marker, Not a Body Store

This is the single most important thing to understand before you read your result. Urinary aflatoxin reflects the last few days of eating, not your lifetime burden. AFM1 is cleared within roughly 1 to 4 days, and the unchanged toxin appears mainly within the first day.

That short window is why a single urine result can look clean even in someone with steady, long-running exposure. Blood-based aflatoxin markers (aflatoxin-albumin, measured in serum rather than urine) capture exposure over roughly 2 to 3 months and answer a different question about cumulative burden.

Where Exposure Comes From

The molds that make aflatoxin grow on crops when they are stored warm, damp, or too long. The foods named most often are maize, groundnuts and peanuts, tree nuts, rice, spices, and dried fruit, while milk contributes mainly through AFM1. Handling contaminated grain during milling can also expose people through dust and skin contact, though diet is the dominant route.

Because contamination varies sharply by region, season, and storage, detection rates swing widely. Across surveys, urinary AFM1 has been found in as few as 2% of samples in one rural Chilean group and in as many as 96% of samples in a Bangladeshi mill-worker study. Your own result depends heavily on where your food comes from and how it was stored.

Liver Cancer Risk

The strongest human evidence links higher urinary aflatoxin to future HCC (hepatocellular carcinoma, the main type of liver cancer). This is the reason the marker matters at all, and the data come from long-running studies that measured the toxin in urine, exactly what this test does.

In a study of 18,244 men in Shanghai, those with any detectable urinary aflatoxin were about 2.4 times as likely to develop liver cancer, rising to about 3.8 times as likely after accounting for hepatitis B, smoking, alcohol, and education. When the specific DNA-damage product (aflatoxin-N7-guanine) was detectable, the reported risk ran several times higher still. In a separate Taiwanese study, people with urinary aflatoxin above the group average had about 76% higher odds of liver cancer, and among those without hepatitis B, the highest quarter of exposure carried roughly 5 times the risk of the lowest quarter.

What this means for you: a detectable or rising result is not a cancer diagnosis, but it flags an exposure pathway worth closing, especially if you have other liver risks. The practical move is to identify and reduce the food source, then confirm the change with a repeat test.

Why Hepatitis Multiplies the Danger

Aflatoxin and chronic viral hepatitis are far more dangerous together than either alone. In the Taiwanese data, carriers of hepatitis B with high urinary aflatoxin had about 15 times the odds of liver cancer, while hepatitis B alone carried roughly 7.5 times the risk. Broader studies using blood-based aflatoxin markers (serum adducts, a related but different measurement) show the same amplifying effect with hepatitis C infection and heavy alcohol use.

This is why your hepatitis B and C status changes how a positive aflatoxin result should be read. If you carry either virus, or drink heavily, a detectable exposure marker deserves more attention than it would in someone with a healthy, uninfected liver.

Acute Poisoning at Very High Doses

At extreme exposure levels, aflatoxin causes acute poisoning called aflatoxicosis, with jaundice, vomiting, abdominal pain, and sudden liver failure. A 2004 outbreak in Kenya from heavily contaminated maize caused 317 cases and 125 deaths.

This is a rare, disaster-scale event tied to grossly contaminated staples, not the low-level dietary exposure most urine testing detects. It is included here for completeness, not because a typical positive result implies acute risk.

Other Associations Under Study

Beyond the liver, aflatoxin exposure has been linked in human studies to immune suppression (including lower CD4 immune-cell counts in people with HIV), impaired growth in children, and possible effects during pregnancy. These links are less consistent and often rest on blood markers rather than urine, so they should be read as areas of active research, not settled conclusions.

Why a Single Reading Can Fool You

Because urinary aflatoxin turns over in days, a single sample is easy to misread. A few factors matter most:

  • Recent meals: the result mostly reflects what you ate in the last day or two, so a clean sample can follow a period of low intake even when your usual diet carries more exposure.
  • Urine dilution: how much water you drank changes the raw concentration, which is why results are often corrected to creatinine, a substance used to standardize urine samples.
  • Lab sensitivity: different testing methods have different detection limits, so a result read as "not detected" in one lab might register in a more sensitive one.
  • Which molecule was measured: the unchanged toxin can be absent while its metabolite AFM1 is present, so a negative for one form does not rule out exposure.

A low or undetectable result usually means low recent exposure. It does not rule out earlier or ongoing exposure, because this marker simply cannot see back more than a few days.

Why Tracking Beats a Single Test

This marker is highly variable by nature, driven by day-to-day diet and by season. In Bangladeshi cohorts, urinary AFM1 differed by season and between rural and urban areas, so one reading is a snapshot of a moving target.

Repeated sampling is far more informative. Get a baseline, and if you change your food sources or storage habits, retest in a few weeks to a few months to see whether exposure actually fell. If you live with ongoing exposure risk, at least annual checks make sense. Because this is a newer, exploratory measurement without standardized clinical cutoffs, building your own trend line is exactly what gives the number meaning over time.

What an Unexpected Result Should Prompt

A detectable or high result is a cue to act on exposure and context, not to panic. Start by reviewing likely food sources and how they are stored, and repeat the test on a fresh sample to confirm it was not a one-off dietary spike.

Then widen the picture with companion testing: your hepatitis B and C status, liver enzymes such as ALT and AST (markers of liver-cell stress), GGT (gamma-glutamyl transferase, another liver enzyme that has run higher in more heavily exposed people), and, in higher-risk situations, AFP (alpha-fetoprotein, a liver-cancer screening blood marker). A serum aflatoxin-albumin test can add the longer-window view that urine cannot.

The combination is what drives decisions. Detectable urine plus hepatitis B or C plus abnormal liver tests is a pattern that warrants a hepatologist and closer surveillance. Isolated low-level detection with normal liver tests and no viral hepatitis usually calls for reducing the food source and rechecking, rather than an urgent workup.

What Moves This Biomarker

Evidence-backed interventions that affect your AFB1 level

Decrease
Reduce aflatoxin in your diet by swapping contaminated staples for lower-risk foods and improving storage
Cutting aflatoxin out of your diet is the most direct way to bring this number down, because the test reflects what you have eaten in the last few days. When infants in rural Tanzania were switched to a low-aflatoxin porridge, the share with detectable urinary AFM1 (the main aflatoxin product this test picks up) fell from 42% to 8%, an 81% drop. In West Africa, better groundnut storage kept a related blood marker (aflatoxin-albumin, measured in serum rather than urine) at less than half the level seen in households without storage changes.
DietStrong Evidence
Decrease
Chlorophyllin taken at 100 mg three times daily
Chlorophyllin, a plant-derived compound, cut the excretion of aflatoxin-DNA adducts in urine by roughly half (about 55%) over 4 months in a double-blind randomized trial, meaning less of the toxin was binding to DNA. It works largely by trapping aflatoxin in the gut so less is absorbed. The trial measured urinary AFB1-N7-guanine adducts specifically, a closely related aflatoxin marker rather than AFM1, so it maps onto this test's biology but was not measured as AFM1 directly.
SupplementModerate Evidence
Decrease
Oltipraz, a drug that shifts the liver toward detoxifying aflatoxin
Oltipraz pushes your liver to detoxify aflatoxin rather than activate it into its DNA-damaging form. In randomized studies in high-exposure Chinese communities, an intermittent high-dose regimen lowered urinary aflatoxin-N7-guanine and serum aflatoxin-albumin, while a daily low-dose regimen mainly raised excretion of a detox byproduct. This is a research and high-risk-population intervention, not a routine consumer supplement.
MedicationModerate Evidence
Decrease
Broccoli sprout beverages rich in a detox-activating compound
Broccoli sprout drinks switch on your liver's detox enzymes, but in a randomized trial in China they did not lower urinary aflatoxin-DNA adducts overall compared with placebo. Only among people who absorbed the active compound well did higher detox-metabolite excretion track with lower aflatoxin-DNA damage, a subgroup pattern rather than a confirmed effect. These studies tracked detoxification metabolites rather than AFM1 directly, so any benefit for this specific test is unproven. It is a low-cost, food-based approach still under study.
DietModest Evidence

Frequently Asked Questions

References

38 studies
  1. Wu HC, Wang Q, Yang HI, Ahsan H, Tsai W, Wang LY, Chen SY, Chen CJ, Santella RCancer Epidemiology, Biomarkers & Prevention2009
  2. Ross R, Yu M, Henderson B, Yuan J, Qian G, Tu J, Gao YT, Wogan G, Groopman JLancet1992
  3. A Follow-up Study of Urinary Markers of Aflatoxin Exposure and Liver Cancer Risk in Shanghai, People's Republic of China
    Qian G, Ross R, Yu M, Yuan JM, Gao Y, Henderson B, Wogan G, Groopman JCancer Epidemiology, Biomarkers & Prevention1994
  4. Chu YJ, Yang HI, Wu HC, Lee MH, Liu J, Wang LY, Lu SN, Jen C, You S, Santella R, Chen CJEuropean Journal of Cancer2018
  5. Chu YJ, Yang HI, Wu HC, Liu J, Wang LY, Lu SN, Lee MH, Jen C, You S, Santella R, Chen CJInternational Journal of Cancer2017